期刊列表 » 期刊详情

1、投稿方式：在线投稿。

2、刊内网址（202504期）：

https://www.keaipublishing.com/en/journals/intelligent-oncology/

3、投稿系统：

https://www2.cloud.editorialmanager.com/intonc/default2.aspx

4、刊内电话：023-68588817

5、刊内邮箱：EditorialOffice@intelligent-oncology.net

6、出刊日期：季刊，逢季末月出版。

7、官方微信公众号：智能肿瘤学（intelligentoncology）

2026年3月12日星期四

Guide for Authors

【官网信息】

Introduction

Types of paper

Full-length/ Research Article (Word limit: 7000)

A complete report on original research and/or clinical studies.

A structured abstract is required.

A clear structure is required, which should contain but not confined to the following sections:

Introduction

Material and methods

Results

Discussion

Conclusions

Authors' contribution (For details please visit the link.)

Ethic statement

COI

(acknowledgments/clarification)

Bibliography

Appendices (including multimedia components)

Review Article (Word limit: 9000)

A

substantial overview presents a complete overview of the state of the

art with a comprehensive bibliography, generally, also contains a table

of contents. It should cover topics that have seen significant

development or progress in recent years, with comprehensive depth and a

balanced perspective. Review articles should NOT include unpublished

material such as unpublished/original data, submitted manuscripts, or

personal communication.

Editorial(Word limit: 1000)

Generally from the (guest) editor of the publication. Can be Foreword, Editorial, Guest Editorial, Preface, etc.

Short Communication (Word limit: 2000)

Short

report or announcement of research, usually claiming certain results,

which present original and significant material for rapid dissemination.

Short Communications are expected to have a higher than average impact

on the field rather than report on incremental research.

Guideline/Consensus (Word limit: 10000)(for clinical medicine only)

Guidelines:

Documents that have been locally or internationally approved and

contain general principles that may benefit others in their clinical

practice or in writing their own guidelines.

Consensus:

Evidence-based analyses of issues that integrate findings, ideas and/or

conceptual frameworks from a variety of sources in a clear and balanced

way.

Meeting Reports, News and Announcements (Word limit: 1500)

Meeting

reports Summary of a relevant symposium, workshop, etc. Or, information

about a conference (can be a description of the venture, but also a

visit report of a scientist who has attended a conference).

Letter to the Editor (Word limit: 2,000)

Any

items of interest to the wide audience of the publication. The items

include a letter to the editor commenting on previously published

articles or a reply to the letter. (The letter or reply needs a

'refers-to' DOI or PII number; or argumentative communication, like

papers in a discussion, or commentaries, etc.(Subsequent discussion

papers need a 'refers-to' DOI or PII number).

Perspective (Word limit: 3000)

An

article presents a new and unique viewpoint on existing problems,

fundamental concepts, or prevalent notions on a specific topic, propose

and support a new hypothesis, or discuss the implications of a newly

implemented innovation. Perspective pieces may focus on current advances

and future directions on a topic and may include original data as well

as personal opinion.

As

a guideline, Perspective should not normally exceed 3,000 words.

Perspectives allow up to 30 references; citations should be selective.

Perspectives should include no more than 4 display items (figures,

tables and/or boxes).

Submission checklist

You

can use this list to carry out a final check of your submission before

you send it to the journal for review. Please check the relevant section

in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

E-mail address

Full postal address

All necessary files have been uploaded:

Manuscript

Include keywords

All figures (include relevant captions)

All tables (including titles, description, footnotes)

Ensure

all figure and table citations in the text match the files provided;

Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations:

Manuscript has been 'spell checked' and 'grammar checked'

All references mentioned in the Reference List are cited in the text, and vice versa

Permission has been obtained for use of copyrighted material from other sources (including the Internet)

A competing interests statement is provided, even if the authors have no competing interests to declare

Journal policies detailed in this guide have been reviewed

For further information, visit our Support Center.

Before you begin

Ethics in Publishing

For

information on Ethics in Publishing and Ethical guidelines for journal

publication see https://www.elsevier.com/publishingethics and

https://www.elsevier.com/ethicalguidelines.

Submissions

to KeAi journals are automatically screened using iThenticate's

CrossCheck within the editorial system to detect plagiarism issues

including instances of overlapping and similar text in submitted

manuscripts. Details can be found here. High similarity papers will be

desk rejected.

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

• include a statement on ethics approval and consent (even where the need for approval was waived)

•include the name of the ethics committee that approved the study and the committee's reference number if appropriate.

All

materials must adhere to high ethical and animal welfare standards. Any

use of animals must be based on ethological knowledge and respect for

species-specific requirements for health and well-being. A statement

indicating that the protocol and procedures employed were ethically

reviewed and approved, and the name of the body giving approval, must be

included in the Methods section of the manuscript.

Consent for publication:

If

your research or manuscript contains any individual person's data in

any form (including any individual details, images or videos), consent

for publication must be obtained from that person, or in the case of

children, their parent or legal guardian. All presentations of case

reports must have consent for publication.

Declaration of generative AI in scientific writing

Authors

can declare the use of generative AI in scientific writing upon

submission of the paper. The following guidance refers only to the

writing process, and not to the use of AI tools to analyze and draw

insights from data as part of the research process:

Generative

AI and AI-assisted technologies should only be used in the writing

process to improve the readability and language of the manuscript.

The

technology must be applied with human oversight and control and authors

should carefully review and edit the result, as AI can generate

authoritative-sounding output that can be incorrect, incomplete or

biased. Authors are ultimately responsible and accountable for the

contents of the work.

Authors

must not list or cite AI and AI-assisted technologies as an author or

co-author on the manuscript since authorship implies responsibilities

and tasks that can only be attributed to and performed by humans.

The

use of generative AI and AI-assisted technologies in scientific writing

can be declared by adding a statement at the end of the manuscript when

the paper is first submitted. The statement will appear in the

published work and should be placed in a new section before the

references list. An example:

Title of new section: Declaration of generative AI and AI-assisted technologies in the writing process.

Statement:

During the preparation of this work the author(s) used [NAME TOOL /

SERVICE] in order to [REASON]. After using this tool/service, the

author(s) reviewed and edited the content as needed and take(s) full

responsibility for the content of the published article.

The

declaration does not apply to the use of basic tools, such as tools

used to check grammar, spelling and references. If you have nothing to

disclose, you do not need to add a statement.

We advise you to read our policy for authors on the use of generative AI and AI-assisted technologies for Elsevier.

Please

note: to protect authors’ rights and the confidentiality of their

research, this journal does not currently allow the use of Generative AI

or AI-assisted technologies such as ChatGPT or similar services by

reviewers or editors in the peer review and manuscript evaluation

process. We are actively evaluating compliant AI tools and may revise

this policy in the future.

Studies in humans and animals

If

the work involves the use of human subjects, the author should ensure

that the work described has been carried out in accordance with The Code

of Ethics of the World Medical Association (Declaration of Helsinki)

for experiments involving humans. The manuscript should be in line with

the Recommendations for the Conduct, Reporting, Editing and Publication

of Scholarly Work in Medical Journals and aim for the inclusion of

representative human populations (sex, age and ethnicity) as per those

recommendations. The terms sex and gender should be used correctly.

The

author should ensure that the manuscript contains a statement that all

procedures were performed in compliance with relevant laws and

institutional guidelines and have been approved by the appropriate

institutional committee(s). This statement should contain the date and

reference number of the ethical approval(s) obtained. Authors should

also include a statement in the manuscript that informed consent was

obtained for experimentation with human subjects. The privacy rights of

human subjects must always be observed.

The

journal will not accept manuscripts that contain data derived from

unethically sourced organs or tissue, including from executed prisoners

or prisoners of conscience, consistent with recommendations by Global

Rights Compliance on Mitigating Human Rights Risks in Transplantation

Medicine. For all studies that use human organs or tissues authors must

provide sufficient evidence that they were procured in line with WHO

Guiding Principles on Human Cell, Tissue and Organ Transplantation. The

source of the organs or tissues used in clinical research must be

transparent and traceable. Authors of manuscripts describing organ

transplantation must additionally declare within the manuscript:

that autonomous consent free from coercion was obtained from the donor(s) or their next of kin; and

that organs/tissues were not sourced from executed prisoners or prisoners of conscience.

All

animal experiments should comply with the ARRIVE guidelines and should

be carried out in accordance with the U.K. Animals (Scientific

Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU

for animal experiments, or the National Research Council's Guide for

the Care and Use of Laboratory Animals and the authors should clearly

indicate in the manuscript that such guidelines have been followed. The

sex of animals must be indicated, and where appropriate, the influence

(or association) of sex on the results of the study.

Declaration of interests

All

authors must disclose any financial and personal relationships with

other people or organizations that could inappropriately influence

(bias) their work. Examples of potential competing interests include

employment, consultancies, stock ownership, honoraria, paid expert

testimony, patent applications/registrations, and grants or other

funding. Authors should complete the declaration of competing interest

statement using this template and upload to the submission system at the

Attach/Upload Files step. Note: Please do not convert the .docx

template to another file type. Author signatures are not required. If

there are no interests to declare, please choose the first option in the

template. This statement will be published within the article if

accepted. More information.

Submission declaration and verification

Submission

of an article implies that the work described has not been published

previously (except in the form of an abstract or as part of a published

lecture or academic thesis), that it is not under consideration for

publication elsewhere, that its publication is approved by all authors

and tacitly or explicitly by the responsible authorities where the work

was carried out, and that, if accepted, it will not be published

elsewhere including electronically in the same form, in English or in

any other language, without the written consent of the

copyright-holder.To verify originality, your article automatically

screened by the originality detection service CrossCheck.

......

更多详见：

https://www.keaipublishing.com/en/journals/intelligent-oncology/guide-for-authors/